U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT06948929) titled 'Synbiotic Formula (SCV09) in Alzheimer's Disease Patients' on April 28.
Brief Summary: In recent years, emerging studies have revealed the role of gut microbiota in human health and diseases, including AD and other neurodegenerative conditions5. Although the underlying mechanism is still largely unknown, successful therapies targeting the gut-brain axis may serve as indirect evidence of the possible linkage.
This pilot, single-arm study aims to estimate the efficacy and assess the safety profile of the use of a new synbiotic formula (SCV09) in improving dementia-related behaviour in Alzheimer's disease patients, paving the way for...